We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Exonucleases Attack Chromosomes with Shortened Telomeres

By Biotechdaily staff writers
Posted on 15 Dec 2003
Researchers have found that enzymatic attack at the ends of shortened telomeres is the principal early cause of loss of genetic information and occurs before repair enzymes fuse shortened telomeres together. More...
They postulated that enzymatic damage occurs before telomeres fuse and become randomly broken during subsequent cell divisions.

Telomeres are a complex of repetitive DNA sequences that cap the ends of chromosomes. Telomeres play a role in cellular replication via the telomerase enzyme, which helps determine whether cells are able to replicate. Telomeres shorten each time a cell divides, and signal cell senescence when they reach a critical length.

Investigators at Johns Hopkins University (Baltimore, MD, USA) worked with a yeast model to establish the sequence of events that occur when telomeres become shortened. They inserted genetic markers into a yeast chromosome and followed the loss of these markers as the telomeres shortened. Their paper in the December 2003 issue of Molecular and Cellular Biology revealed that markers at the very end of the chromosome were most likely to be lost, and markers closest to the center of the chromosome the least likely.

"If fusion and breakage was the primary mechanism of gene loss, the pattern of loss would have been random--each marker would have been just as likely as the others to be lost,” explained senior author Dr. Carol Greider, professor of molecular biology and genetics at the Johns Hopkins School of Medicine. "The marker loss we saw was not at all random, so we knew some other mechanism was at work. We demonstrated that fused chromosomes do break randomly, at which point exonucleases attack the exposed ends. Fusion is a big part of what leads to major genomic instability when telomeres aren't working, but it's not the initial problem. Our discovery should spark researchers in the field to think along new lines.”




Related Links:
Johns Hopkins University

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.